ChromaDex Corporation
Index- P/E- EPS (ttm)-0.41 Insider Own1.30% Shs Outstand66.33M Perf Week6.13%
Market Cap114.75M Forward P/E- EPS next Y-0.19 Insider Trans2.99% Shs Float41.06M Perf Month-20.28%
Income-27.10M PEG- EPS next Q-0.08 Inst Own32.50% Short Float8.38% Perf Quarter-37.09%
Sales67.40M P/S1.70 EPS this Y-23.80% Inst Trans5.54% Short Ratio7.23 Perf Half Y-71.02%
Book/sh0.52 P/B3.33 EPS next Y71.40% ROA- Target Price10.06 Perf Year-77.65%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range1.51 - 10.78 Perf YTD-53.74%
Dividend- P/FCF- EPS past 5Y-33.50% ROI- 52W High-83.95% Beta1.80
Dividend %- Quick Ratio1.60 Sales past 5Y25.50% Gross Margin61.50% 52W Low14.57% ATR0.16
Employees115 Current Ratio2.40 Sales Q/Q17.70% Oper. Margin- RSI (14)42.10 Volatility12.37% 8.77%
OptionableYes Debt/Eq0.00 EPS Q/Q- Profit Margin- Rel Volume0.51 Prev Close1.83
ShortableYes LT Debt/Eq0.00 EarningsMay 12 AMC Payout- Avg Volume475.80K Price1.73
Recom1.60 SMA20-6.91% SMA50-20.71% SMA200-61.71% Volume241,196 Change-5.46%
Mar-08-22Initiated ROTH Capital Buy $7
Oct-16-19Initiated Oppenheimer Outperform $6
Feb-14-19Initiated B. Riley FBR Buy $7
Nov-27-17Resumed H.C. Wainwright Buy $6 → $8
Sep-25-17Initiated Ladenburg Thalmann Buy $7
Jan-03-17Initiated Rodman & Renshaw Buy $6
May-17-22 08:27AM  
May-12-22 05:35PM  
May-09-22 08:25AM  
May-05-22 08:35PM  
Apr-29-22 06:32AM  
Apr-28-22 03:02PM  
Apr-22-22 06:34AM  
Apr-14-22 06:32AM  
Apr-06-22 06:32AM  
Mar-29-22 10:55AM  
Mar-18-22 06:18AM  
Mar-16-22 06:31AM  
Mar-09-22 05:15PM  
Mar-08-22 08:35AM  
Mar-02-22 06:33AM  
Mar-01-22 04:24AM  
Feb-22-22 06:34AM  
Feb-09-22 06:34AM  
Jan-31-22 06:32AM  
Jan-25-22 06:32AM  
Jan-22-22 07:08AM  
Jan-20-22 10:39AM  
Dec-08-21 05:29AM  
Nov-04-21 01:30AM  
Nov-03-21 05:55PM  
Oct-27-21 03:04PM  
Oct-24-21 08:49AM  
Oct-18-21 06:34AM  
Oct-13-21 06:33AM  
Oct-01-21 06:33AM  
Sep-29-21 06:37AM  
Sep-20-21 06:33AM  
Sep-15-21 04:16PM  
Sep-09-21 06:33AM  
Aug-10-21 01:22AM  
Aug-03-21 10:31PM  
Jul-27-21 03:02PM  
Jul-20-21 06:33AM  
Jul-11-21 04:11AM  
Jun-16-21 10:35AM  
Jun-11-21 01:38AM  
Jun-08-21 10:40AM  
Jun-07-21 12:19PM  
Jun-02-21 02:50AM  
May-07-21 04:30PM  
May-06-21 06:20PM  
May-04-21 06:33AM  
May-03-21 06:33AM  
Apr-29-21 06:33AM  
Apr-28-21 06:33AM  
Apr-19-21 06:33AM  
Mar-31-21 06:33AM  
Mar-28-21 04:18AM  
Mar-24-21 06:33AM  
Mar-22-21 08:42AM  
Mar-18-21 06:33AM  
Mar-16-21 06:48PM  
Mar-11-21 12:00AM  
Mar-10-21 05:35PM  
Mar-09-21 06:32AM  
Mar-08-21 09:00AM  
Mar-03-21 12:30PM  
Feb-24-21 06:30AM  
Feb-22-21 06:30AM  
Feb-20-21 02:17AM  
Feb-19-21 06:35AM  
Feb-12-21 01:13PM  
Feb-04-21 06:35AM  
Dec-22-20 12:28AM  
Dec-14-20 08:32AM  
Dec-02-20 03:49PM  
Nov-17-20 06:35AM  
Nov-09-20 06:32AM  
Nov-07-20 08:32AM  
Nov-04-20 11:32PM  
ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingredients directly to consumers, as well as to distributors; and develops and commercializes proprietary-based ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. The company also commercializes NAD+ precursor nicotinamide riboside as the flagship ingredient NIAGEN; NIAGEN as an active ingredient in its consumer products under the TRU NIAGEN name; and IMMULINA, a Braun-type lipoproteins, including spirulina extracts and active compounds, which are used to support human immune function. It also offers analytical reference standards and services comprising supply of products to conduct quality control of raw materials and consumer products in dietary supplements, cosmetics, food and beverages, life sciences, and pharmaceutical industries. The company distributes TRU NIAGEN products direct to consumers through its propriety ecommerce platform, Amazon, and other internet marketplaces, as well as specialty retailers and direct healthcare practitioners in the United States. ChromaDex Corporation is headquartered in Los Angeles, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Fried Robert NCEOMar 16Buy2.1625,00054,00088,001Mar 16 07:28 PM